Certain supplements require caution or avoidance during tirzepatide therapy due to potential interactions, overlapping effects, or safety concerns
Sathe AP, Kumar A, Mandlik R, Raturi G, Yadav H, Kumar N, Shivaraj SM, Jaswal R, Kapoor R, Gupta SK, Sharma TR, Sonah H
Wadden and colleagues assessed changes in depressive symptoms using the Patient Health Questionnaire-9 (PHQ-9) and suicidal ideation or behaviors using the Columbia Suicide Severity Rating Scale in participants with overweight or obesity using semaglutide 2.4 mg or placebo
The semaglutide Summary of Product Characteristics (SmPC) notes the diabetic retinopathy findings from SUSTAIN-6 and recommends appropriate monitoring for patients with diabetic retinopathy
Your doctor will make a dose adjustment slowly according to your bodys response and tolerance